Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it

?w=2048

A new generation of longevity biotech companies with a more conservative approach than their predecessors has emerged—but investment remains constrained.

https://fortune.com/2024/09/09/aging-inflation-life-longevity-biotech-investing/